baber/WOPTO huggingface dataset:
Patent JP-3143707-B2 (JP)
IPC: C25D5/56
Filed: 1992-06-17
Granted: 2001-03-07
Abstract: Novel aqueous accelerating solutions and methods for their use in connection with direct electroplating of dielectric basis materials are disclosed and claimed. The accelerating solutions are mildly basic aqueous solutions including dilute concentrations of copper ions.
Patent JP-3085710-B2 (JP)
IPC: C07D305/14
Filed: 1992-07-08
Granted: 2000-09-11
Abstract: Process for the preparation of a taxane derivative of general formula (I) and use of the product obtained as a preparation of taxane derivatives of general formula (II). In the general formula (I), R1 represents an acetyl radical or a protecting group, G1 represents a protecting group and R represents a t-butoxy of phenyl radical. In the general formula (II), R represents a t-butoxy of phenyl radical and R'1 represents a hydrogen atom or an acetyl radical. <IMAGE>
Patent JP-3933201-B2 (JP)
IPC: D01F2/00
Filed: 1996-06-25
Granted: 2007-06-20
Abstract: The present invention relates to a process for the preparation of a mixture of cellulosic fibers and microfibers. Said process comprises:the preparation of a cellulosic solution (C);the extrusion of said solution (C) through the hole or holes of a die (1);the disintegration of said solution (C) when it comes out of said hole or holes by projecting a liquid or gas fluid (F) in a direction making an angle lower than or equal to 75 degrees with the axis of said die (1); said fluid (F) being neutral or appropriate to regenerate or precipitate, only partially, the cellulose;the reception in a cellulose regeneration or precipitation bath, of the dispersion generated at the disintegration step;the recovery of the mixture of fibers and microfibers, more or less bonded, obtained in said bath. Said process provides for the preparation of mixtures rich in microfibers (with a fineness lower than 1 dtex, particularly between 0.5 and 0.3 dtex). It also provides for the continuous preparation of nonwoven materials.
Patent JP-4073041-B2 (JP)
IPC: C08G59/24
Filed: 1997-07-17
Granted: 2008-04-09
Abstract: The invention relates to a single-component adhesive system that consists at least of a casting resin, in particular of an epoxy casting resin, and a multivalent alcohol. The low-viscosity adhesive system can be microdosed, is stable in storage, is completely hardenable and is suitable for applications in which the dimensional tolerances are in the mum and sub-mum region.
Patent JP-3112936-B2 (JP)
IPC: C12N15/12
Filed: 1991-04-03
Granted: 2000-11-27
Abstract: The new polypeptides have a defined of 446 amino acids or comprise fragments of it; provided the fragments; (i) contain at least those sites necessary for, when the fragment is exposed at the surface of a cell, binding to its (ant)agonists, specifically and in a measurable way (e.g. by means of a radioative ligand); (ii) can be recognised by Abs which recognise the full sequence but not dopaminergic D1 or D2 receptors; or (iii) can generate Abs recognising the full sequence but not dopaminergic receptor D1 or D2. The polypeptides include variants having licalised mutations provided they have not lost their dopaminergic receptor properties. Preferrred polypeptides show agonist affinity, by competition with the ligand iodosulphide-1 125, in the order quinpirole greater than apomorphine = dopamine and antagonist activity in the order raclopiriae greater than UH232 = haloperidol. DNA encoding the polypeptides, recombinant vectors and transformed hosts are also claimed. Antibodies to the peptides and nucleotide probes are claimed. Also claimed are diagnostic methods and kits specifically for pathologic expression of dopaminergic D3 receptor and genetic abnormalities of D3 receptor (in vitro).
Patent JP-3274470-B2 (JP)
IPC: H04S5/02
Filed: 1995-11-08
Granted: 2002-04-15
Abstract: PCT No. PCT/NL95/00384 Sec. 371 Date May 7, 1997 Sec. 102(e) Date May 7, 1997 PCT Filed Nov. 8, 1995 PCT Pub. No. WO96/14723 PCT Pub. Date May 17, 1996Loudspeaker system having various loudspeakers (SPi, i=0, 1, 2, . . . , m) which are arranged in accordance with a predetermined pattern and have associated filters (Fi, i=0, 1, 2, . . . , m), which filters all receive an audio signal (AS) and are equipped to transmit output signals to the respective loudspeakers (SPi) such that they, during operation, generate a sound pattern of a predetermined form, wherein the loudspeakers (SPi) have a mutual spacing (li), which, insofar as physically possible, substantially corresponds to a logarithmic distribution, wherein the minimum spacing is determined by the physical dimensions of the loudspeakers used.
Patent JP-3137292-B2 (JP)
IPC: C02F1/46
Filed: 1994-01-24
Granted: 2001-02-19
Abstract: PCT No. PCT/GB94/00129 Sec. 371 Date Jul. 24, 1995 Sec. 102(e) Date Jul. 24, 1995 PCT Filed Jan. 24, 1994 PCT Pub. No. WO94/17000 PCT Pub. Date Aug. 4, 1994A fluid treatment device, especially for reducing or removing the effects of hard water, has a fluid inlet, a fluid outlet, and a cavity extending between the inlet and the outlet. A dielectric channel separator (preferably of plastics material, more preferably PTFE) is located in the cavity between the inlet and the outlet and extends at least part way along the cavity. The dielectric channel separator divides thecavity into a plurality of elongate channels which are mutually coextensive for at least part of their length in the direction of fluid flow from the inlet to the outlet and are at least partially bounded by dielectric material. A metallic channel separator, preferably of zinc, can also be provided to provide a degree of protection against corrosion. The channel separators are preferably configured to encourage turbulence in the fluid flowing through the device.
Patent JP-3241048-B2 (JP)
IPC: A61K8/00
Filed: 1996-10-23
Granted: 2001-12-25
Abstract: PCT No. PCT/FR96/01658 Sec. 371 Date Apr. 29, 1998 Sec. 102(e) Date Apr. 29, 1998 PCT Filed Oct. 23, 1996 PCT Pub. No. WO97/16165 PCT Pub. Date May 9, 1997The use of carboxylic acids having a thioether function, a sulphoxide function or a sulphone function in or for making a cosmetic or dematological composition for promoting skin exfoliation and/or stimulating epidermal regeneration, is disclosed. The use of said composition for controlling intrinsic and extrinsic skin ageing, and a non-therapeutic skin treatment method useful for skin exfoliation, are also disclosed.
Patent JP-3881692-B2 (JP)
IPC: C07C319/20
Filed: 1995-12-18
Granted: 2007-02-14
Abstract: The present invention relates to benzamidoxime derivatives represented by the formula ÄIÜ; <CHEM> wherein R<1> is unsubstituted or substituted C1 - C4 alkyl, unsubstituted or substituted C2 - C4 alkenyl or unsubstituted or substituted C2 - C4 alkynyl, R<2> is phenyl optionally having substituents or heterocycle optionally having substituents, X<1>, X<2>, X<3> and X<4> are each independently hydrogen, halogen, C1 - C4 alkyl, C1 - C4 haloalkyl, C1 - C4 alkoxy, C1 - C4 haloalkoxy, C1 - C4 alkylthio or the like, and r1 and r2 are each independently hydrogen, C1 - C4 alkyl or the like, having excellent fungicidal activity and being useful as a fungicide for agricultural and horticultural use, and methods for preparation thereof.
Patent JP-3348858-B2 (JP)
IPC: A61K31/135
Filed: 1995-02-22
Granted: 2002-11-20
Abstract: PCT No. PCT/EP95/00658 Sec. 371 Date Dec. 24, 1996 Sec. 102(e) Date Dec. 24, 1996 PCT Filed Feb. 22, 1995 PCT Pub. No. WO95/23602 PCT Pub. Date Sep. 8, 1995Oral antitussive pharmaceutical composition which allows a significant contact of its components with mucous membranes of the buccal cavity and comprises a centrally acting antitussive or a pharmaceutically acceptable salt thereof and benzydamine or a pharmaceutically acceptable acid addition salt thereof.
Patent JP-3511139-B2 (JP)
IPC: A61K31/55
Filed: 1996-01-26
Granted: 2004-03-29
Abstract: Exochelins can be used to prevent damage to living tissue from the formation or presence of the (.OH) radical. In particular, the invention is directed to the administration of exochelins to infarcted myocardium prior to or coincidental with reperfusion to prevent damage to myocardium from iron mediated free radical formation. Also presented is the chemical structure of exochelins and modified exochelins as well as other applications of these materials in the treatment and diagnosis of disease in mammals.
Patent JP-3025015-B2 (JP)
IPC: G01N35/08
Filed: 1994-04-28
Granted: 2000-03-27
Abstract: PCT No. PCT/DK94/00169 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Apr. 28, 1994 PCT Pub. No. WO94/25875 PCT Pub. Date Nov. 10, 1994A fully functional analyzing unit is included within the fluid-tight housing of a dialyzer which may be immersed in the medium to be analyzed. An opening in the housing is closed by a dialysis membrane. A channel defining body cooperates with the membrane to define a flow channel. The unit includes a carrier fluid reservoir and a carrier pump for generating a flow of carrier fluid through the flow channel. By dialysis via the membrane, the flow of carrier fluid is transformed into a flow of sample fluid which is received in a reaction channel. Reagent fluid from at least one reagent reservoir is delivered to the reaction channel by at least one reagent pump, and a detecting device is coupled to the reaction channel for detecting a reaction product originating from a reaction between the reagent fluid and the sample fluid and for generating a corresponding detection signal. Effluent from the reaction channel is received in a waste reservoir. Average volume flow in the reaction channel during operation is less than 100  mu l/min, allowing for at least 30 days of uninterrupted operation. The device is suitable for in situ real-time measurement of plant nutrient salts in process waters of waste water treatment plants.
Patent JP-3771581-B2 (JP)
IPC: A61K31/495
Filed: 1995-02-16
Granted: 2006-04-26
Abstract: Naphthalamides are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and as agents for the treatment of disorders which respond to dopaminergic blockade including psychotic depression, substance abuse, and compulsive disorders.
Patent JP-3342014-B2 (JP)
IPC: F01N3/20
Filed: 1994-04-27
Granted: 2002-11-05
Abstract: A method for the controlled introduction of a reducing agent into a nitrogen oxide-containing exhaust gas leaving an internal combustion engine through an exhaust line having a catalytic converter built in for reducing nitrogen oxide, includes detecting at least one operation-relevant parameter of the exhaust gas, of the catalytic converter and optionally of the engine to determine the nitrogen oxide rate. An intermediate value is determined for the reducing agent rate as a function of the nitrogen oxide rate. The intermediate value is reduced by a rate of the reducing agent desorbed by the catalytic converter or raised by a rate of the reducing agent adsorbed by the catalytic converter. An apparatus for performing the method includes a control unit. A device detects at least one operation-relevant parameter of the exhaust gas, of the catalytic converter and optionally of the engine. A reducing agent supply unit introduces the reducing agent into the exhaust line upstream of the catalytic converter. The control unit is intended to adjust a rate of the reducing agent introduced into the exhaust gas as a function of the parameters, while taking into account a rate of the reducing agent adsorbed by the catalytic converter or desorbed by the catalytic converter.
Patent JP-4017674-B2 (JP)
IPC: D06M15/11
Filed: 1997-11-26
Granted: 2007-12-05
Abstract: A rinse-added fabric conditioning composition comprising a starch having a gelatinization temperature of less than 150 degrees C. and a method of imparting crispness properties to fabrics treated with same.
Patent JP-4027422-B2 (JP)
IPC: G11B7/006
Filed: 1997-02-14
Granted: 2007-12-26
Abstract: A recording layer of rewritable phase-change material is directly overwritten by a pulsing laser spot irradiating at a writing power level, then irradiating at a lower cool-down power level during a cool-down period, and then irradiating at an erasing level with a higher power than the cool-down level. The duration of the cool-down period depends on the spot size and/or on the linear velocity of the spot with respect to the recording layer.
Patent JP-3288708-B2 (JP)
IPC: A61K39/00
Filed: 1994-05-16
Granted: 2002-06-04
Abstract: A method for the production of antigen-specific cytotoxic T-cells (CTLs) by incubating a T cell-containing cell preparation with said antigen and isolating said antigen-specific CTLs, characterized by i) activating proliferation of CTLs in the cell preparation by incubation with the antigen; ii) selectively transferring a vector into the proliferating CTLs, said vector containing a marker gene by means of which marked and non-marked cells can be separated; and iii) separating the transfected antigen-specific CTLs on the basis of said marker gene, is useful for immunomodulation.
Patent JP-2843827-B2 (JP)
IPC: C08L1/12
Filed: 1996-05-14
Granted: 1999-01-06
Abstract: PCT No. PCT/EP96/02074 Sec. 371 Date Feb. 19, 1997 Sec. 102(e) Date Feb. 19, 1997 PCT Filed May 14, 1996 PCT Pub. No. WO96/36666 PCT Pub. Date Nov. 21, 1996Described are molded bodies comprising bond material based on cellulose acetate as a bonding agent and reinforcing natural cellulose fibers or natural cellulose-containing fibers. These components are characterized by the fact that the cellulose acetate has a degree of substitution (DS) of approximately 1.2 to 2.7 and the molded bodies have a Vicat temperature of at least approximately 160 DEG  C. and the ratio of the weight of cellulose acetate to the natural cellulose fibers or natural cellulose-containing fibers is approximately 10:90-90:10. These molded bodies are produced by mixing cellulose acetate with the natural cellulose fibers or the natural cellulose-containing fibers in a ratio by weight of approximately 90:10-10:90, in particular 15:85-85:15, in the total moisture content is adjusted to at least approximately 3% by weight, with respect to the total amount of the cellulose acetate in the mixture, and this mixture is molded at a temperature of approximately 220 DEG  to 280 DEG  C. and a pressure of approximately 30 to 150 bars. The molded bodies according to the invention can advantageously be used as interior parts of automobiles, in particular as roof ceiling and as side paneling, as well as packaging material, insulating material or as a furniture part.
Patent JP-4388604-B2 (JP)
IPC: C23C16/18
Filed: 1998-03-13
Granted: 2009-12-24
Abstract: PCT No. PCT/FR98/00518 Sec. 371 Date Dec. 15, 1999 Sec. 102(e) Date Dec. 15, 1999 PCT Filed Mar. 13, 1998 PCT Pub. No. WO98/40387 PCT Pub. Date Sep. 17, 1998The invention concerns complex compounds of oxidised copper (+1) stabilised by a ligand for the gas phase chemical deposit of copper in which copper is coordinated with a  beta -diketonate and the ligand is an alkyne of which the triple bond is partially deactivated by one or two groups slightly attracting the electrons by said alkyne.
Patent JP-3981767-B2 (JP)
IPC: F16N3/12
Filed: 1998-03-20
Granted: 2007-09-26
Abstract: A press for extruding lubricating grease has a press head with a high pressure reciprocating pump, a high-pressure outlet opening with a check valve, a low-pressure intake opening for feeding the mass to be extruded to the reciprocating pump, and a connection on the press head for connecting a pipe thereto. The pipe receives therein a grease filled cartridge having a displaceable trailing piston. A cartridge-connecting element has a connection for the cartridge, and the pipe is open at that end thereof oriented away from the press head, whereby when the cartridge is connected to the cartridge-connecting element, it protrudes from the open end of the pipe, is guided radially by the pipe and is retained axially by the cartridge-connecting element.
Patent ES-2181601-B2 (ES)
Title: Derivados de acido araquidonico con afinidad por el transportador de anandamida
Inventor: LOPEZ RODRIGUEZ MARIA LUZ
IPC: A61K31/165
Filed: 2001-07-27
Granted: 2004-04-01
Abstract: La presente invención se refiere a los compuestos derivados de ácido araquidónico de fórmula general I, así como a sus estereoisómeros y sus mezclas, y las sales y solvatos farmacéuticamente aceptables de todos ellos. También se describe un procedimiento para la preparación de los compuestos mencionados, la caracterización farmacológica y las aplicaciones terapéuticas. **FIGURA** En donde: X representa CO, CS o CH{sub, 2} Y representa CH{sub, 2}, O, S, NH, o NR (R representa alquilo, alquilarilo o arilo) Z representa H o un grupo alquilo, alquilarilo o arilo Heterociclo representa una subunidad monocíclica aromática o una subunidad monocíclica alifática constituida por uno o dos heteroátomos y unidades metilénicas o los derivados benzofusionados de ambas subunidades.
Patent ES-2195771-B2 (ES)
Title: Medio de cultivo para la deteccion directa de cepas aflatoxigenicas.
Inventor: VAZQUEZ BELDA BEATRIZ ISABEL
IPC: C12Q1/04
Filed: 2002-02-22
Granted: 2004-10-16
Abstract: Medio de cultivo para la detección directa de cepas aflatoxigénicas, suplementando los medios de cultivo habituales con Cavasol W7M-ciclodextrina y desoxicolato de sodio. La interacción con las aflatoxinas provoca la aparición al 2º ó 3er día de un halo beige muy nítido observable a simple vista con luz natural. El anillo beige observado se corresponde perfectamente con el anillo fluorescente que forman las aflatoxinas cuando se observan bajo luz UV (365 nm).
Patent ES-2384062-B2 (ES)
Title: Acoplador direccional acoplado por ranura y procedimiento de diseño de dicho acoplador
Inventor: MOSCOSO MARTIR ALVARO
IPC: H01P3/08
Filed: 2010-12-03
Granted: 2013-04-29
Abstract: Acoplador direccional acoplado por ranura y procedimiento de diseño de dicho acoplador.#Permite compensar el efecto parásito introducido por las discontinuidades en la propagación de los dos modos par e impar del acoplador, aprovechando por un lado el hecho de la ortogonalidad existente entre los modos par e impar, y por otro lado aprovechando el hecho de que en un acoplador direccional acoplado por ranura, la ranura es transparente al modo impar. Por tanto, mediante el procedimiento aquí descrito se permite el diseño de acopladores direccionales de altas prestaciones, con capacidad de trabajar a frecuencias elevadas, y con un ancho de banda y un nivel de acoplamiento variables en función de las necesidades y requerimientos de cada aplicación.
Patent AU-2001268132-B2 (AU)
Title: Benzamide ligands for the thyroid receptor
Inventor: RYONO DENIS E
IPC: A61P3/04
Filed: 2001-06-01
Granted: 2006-05-18
Abstract: New thyroid receptor ligands are provided which have the general formulain which:X is -O-, -S-, -CH2-, -CO-, or -NH-;R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons;R2 and R3 are the same or different and are hydrogen, halogen, alkyl of 1 to 4 carbons or cycloalkyl of 3 to 6 carbons, at least one of R2 and R3 being other than hydrogen;R4 is methyl, ethyl, n-propyl or trifluoromethyl;R5 is hydrogen or lower alkyl;R6 is carboxylic acid, or esters or prodrugs;R7 is hydrogen or an alkanoyl or an aroyl.In addition, a method is provided for preventing, inhibiting or treating a disease associated with metabolism dysfunction or which is dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount. Examples of such diseases associated with metabolism dysfunction or are dependent upon the expression of a T3 regulated gene include obesity, hypercholesterolemia, atherosclerosis, cardiac arrhythmias, depression, osteoporosis, hypothyroidism, goiter, thyroid cancer as well as glaucoma, congestive heart failure and skin disorders.
Patent AU-2001275226-B2 (AU)
Title: Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
Inventor: HUBBEL JEFFREY A
IPC: C12N15/09
Filed: 2001-06-04
Granted: 2007-06-28
Abstract: The invention features polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups. These biomaterials may be used for medical treatments.
Patent AU-2002240739-B2 (AU)
Title: Electrode seal for arc furnace
Inventor: MCCAFFREY FELIM P
IPC: F27D7/06
Filed: 2002-02-25
Granted: 2006-06-15
Abstract: An electrode seal for an electric arc furnace comprises an annular support ring having an internal diameter substantially greater than the diameter of the electrode, and which is secured to the furnace roof by a plurality of mounting feet. The annular support ring has an upper annular sealing surface on which is supported an annular sealing ring having an internal diameter which is approximately the same as the diameter of the electrode to form a substantial seal therewith. The sealing ring has a lower annular sealing surface which engages the upper sealing surface of the support ring, while allowing limited sliding movement of the sealing ring along its lower annular sealing surface.
Patent AU-2002253815-B2 (AU)
Title: Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
Inventor: COOKE JASON WILLIAM BEAMES
IPC: A61P7/00
Filed: 2001-12-17
Granted: 2005-07-14
Abstract: An improved process for preparing arylethanoldiamines is described. Compounds of this type are known to be useful as agonists at atypical beta-adrenoceptors (also known as beta-3-adrenoceptors).
Patent AU-2002257993-B2 (AU)
Title: Identification plates
Inventor: TAFFINDER RICHARD IVOR
IPC: B41J29/00
Filed: 2002-06-17
Granted: 2007-03-15
Abstract: An identification plate (100) comprises a supporting substrate (20) having an entire retro-reflective major surface (106) and a transparent sheet material (2) having indicia (43) printed thereon, the transparent material (2) being adhered to the retro-reflective surface (106) such that the indicia (43) are located in contact with, or at least adjacent to, the retro-reflective surface (106), characterised in that the supporting substrate (20) has one or more lines of weakness (110) formed therein.
Patent AU-2002322233-B2 (AU)
Title: Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
Inventor: SAMPALIS FOTINI
IPC: C07D407/14
Filed: 2002-07-29
Granted: 2008-10-23
Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.
Patent AU-2002330393-B2 (AU)
Title: Air conditioner
Inventor: KIKUCHI YOSHIMASA
IPC: F24F12/00
Filed: 2002-09-12
Granted: 2006-08-03
Abstract: Disclosed is an air conditioning apparatus which is provided with an adsorption element  (81, 82)  having a humidity adjusting side passageway  (85)  capable of adsorption and desorption of moisture by passage of adsorption air or regeneration air and a cooling side passageway  (86)  through which cooling air passes so that the adsorption air is cooled by absorption of heat of adsorption generated during the adsorption in the humidity adjusting side passageway  (85).  In the air conditioning apparatus, air is humidified or dehumidified in the humidity adjusting side passageway  (85)  of the adsorption element  (81, 82)  and is supplied to an indoor space. In order to achieve improvements in the cooling efficiency when cooling adsorption air by the use of cooling air in the cooling side passageway  (86),  room air (RA), conditioned air (CA), or mixed air (RA + OA) which is a combination of room air (RA) and outdoor air (OA) is used as cooling air which is forced to flow through the adsorption element  (81, 82).